Join to View Full Profile
1000 FivePointIrvine, CA 92618
Phone+1 949-671-4673
Dr. Malhotra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 2006 - 2009
Maulana Azad Medical CollegeClass of 2005
Certifications & Licensure
CA State Medical License 2022 - 2026
NY State Medical License 2010 - 2026
NJ State Medical License 2015 - 2023
DC State Medical License 2006 - 2009
PA State Medical License 2009 - 2009
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer Start of enrollment: 2011 Nov 23
- First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors Start of enrollment: 2017 May 04
- Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy Start of enrollment: 2020 Apr 16
- Join now to see all
Publications & Presentations
PubMed
- Proceedings of the 1st biannual bridging the gaps in lung cancer conference.Narjust Florez, Sandip P Patel, Heather Wakelee, Lyudmila Bazhenova, Erminia Massarelli
The Oncologist. 2025-02-06 - Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond th...Ari A Kassardjian, Jyoti Malhotra, Percy Lee
Translational Cancer Research. 2025-01-31 - 2 citationsTargeting CNS Metastases in Non-Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers: A Review.Jyoti Malhotra, Isa Mambetsariev, Gregory Gilmore, Jeremy Fricke, Arin Nam
JAMA Oncology. 2025-01-01
Press Mentions
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC with Specific Mutations?October 24th, 2024- BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual MeetingMay 24th, 2021
- How Covid Vaccine Diplomacy Is Helping India Win Back Its NeighbourhoodJanuary 15th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
